B Group, Inc.
Net buyer this quarter
$213M
18
+$18.3M
65.5%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 ADMA | $27.3M | 12.82% | 1.45% | +1.7% | Q4 2024 |
 PALI | $23.9M | 11.20% | 6.58% | Not reported | Q4 2025 |
 NRXP | $16.7M | 7.86% | 9.48% | +36.4% | Q1 2026 |
 FTH | $15.3M | 7.16% | 2.36% | New | Q2 2026 |
 TSHA | $12.3M | 5.76% | 0.55% | Not reported | Q4 2024 |
 PRAX | $11.1M | 5.22% | 0.12% | Not reported | Q1 2025 |
 CLLS | $9.84M | 4.62% | 4.57% | Not reported | Q4 2024 |
 ZLAB | $8.56M | 4.02% | 0.04% | Not reported | Q4 2024 |
 GPCR | $7.51M | 3.53% | 0.07% | +9.8% | Q4 2025 |
 ORKA | $7.14M | 3.35% | 0.12% | Not reported | Q4 2024 |
 IOVA | $6.24M | 2.93% | 0.33% | Not reported | Q4 2024 |
 SYRE | $6.21M | 2.92% | 0.08% | -30.0% | Q4 2024 |
 AURA | $5.43M | 2.55% | 0.74% | +27.9% | Q4 2024 |
 ASMB | $4.83M | 2.27% | 0.89% | Not reported | Q4 2024 |
 DRUG | $4.74M | 2.22% | 0.88% | Not reported | Q1 2026 |
 RARE | $4.51M | 2.12% | 0.14% | Not reported | Q4 2024 |
 SGHT | $3.66M | 1.72% | 1.77% | Not reported | Q4 2024 |
 FHTX | $976K | 0.46% | 0.34% | +96.1% | Q1 2026 |
| Q1 2026 | |||||
| ADMA | $28.9M | 21.43% | 1.38% | +30.5% | Q4 2024 |
| PALI | $20M | 14.81% | 6.82% | +153.7% | Q4 2025 |
| PRAX | $10.7M | 7.94% | 0.12% | Not reported | Q1 2025 |
| CLLS | $10.4M | 7.71% | 4.57% | Not reported | Q4 2024 |
| ZLAB | $8.48M | 6.28% | 0.04% | +12.7% | Q4 2024 |
| TSHA | $8.05M | 5.97% | 0.63% | Not reported | Q4 2024 |
| NRXP | $6.39M | 4.74% | 8.96% | New | Q1 2026 |
| GPCR | $6.15M | 4.56% | 0.06% | +41.7% | Q4 2025 |
| IOVA | $5.27M | 3.90% | 0.34% | Not reported | Q4 2024 |
| SYRE | $5.04M | 3.74% | 0.13% | Not reported | Q4 2024 |
| DRUG | $4.93M | 3.65% | 0.88% | New | Q1 2026 |
| ASMB | $4.88M | 3.61% | 1.11% | Not reported | Q4 2024 |
| AURA | $4M | 2.96% | 0.93% | +4.4% | Q4 2024 |
| ORKA | $3.68M | 2.73% | 0.15% | Not reported | Q4 2024 |
| SGHT | $3.66M | 2.71% | 1.80% | +5.4% | Q4 2024 |
| RARE | $2.83M | 2.10% | 0.14% | Not reported | Q4 2024 |
| APGE | $631K | 0.47% | 0.01% | -62.5% | Q4 2024 |
| FHTX | $488K | 0.36% | 0.17% | New | Q1 2026 |
| SLNO | $251K | 0.19% | 0.01% | New | Q1 2026 |
 REPL | $199K | 0.15% | 0.03% | New | Q1 2026 |
| Q4 2025 | |||||
| ADMA | $44.8M | 33.10% | 1.03% | +1.9% | Q4 2024 |
| CLLS | $15.9M | 11.73% | 4.57% | Not reported | Q4 2024 |
| PALI | $10.6M | 7.81% | 2.82% | New | Q4 2025 |
| TSHA | $9.9M | 7.31% | 0.63% | Not reported | Q4 2024 |
| PRAX | $9.8M | 7.23% | 0.13% | +5.5% | Q1 2025 |
| SGHT | $7.3M | 5.39% | 1.72% | -1.1% | Q4 2024 |
| ZLAB | $7.06M | 5.21% | 0.04% | Not reported | Q4 2024 |
| GPCR | $6.26M | 4.62% | 0.04% | New | Q4 2025 |
| ASMB | $5.98M | 4.41% | 1.11% | Not reported | Q4 2024 |
| IOVA | $4.1M | 3.02% | 0.36% | Not reported | Q4 2024 |
| SYRE | $3.28M | 2.42% | 0.13% | Not reported | Q4 2024 |
| AURA | $3.12M | 2.30% | 0.90% | Not reported | Q4 2024 |
| RARE | $3.11M | 2.29% | 0.14% | Not reported | Q4 2024 |
| ORKA | $2.27M | 1.68% | 0.15% | Not reported | Q4 2024 |
| APGE | $1.51M | 1.11% | 0.03% | -42.9% | Q4 2024 |
| Q3 2025 | |||||
| ADMA | $35.4M | 26.02% | 1.01% | +4.1% | Q4 2024 |
| ZLAB | $13.6M | 9.97% | 0.04% | Not reported | Q4 2024 |
| AKRO | $11M | 8.12% | 0.29% | Not reported | Q4 2024 |
| CLLS | $9.35M | 6.88% | 4.57% | +0.8% | Q4 2024 |
| TSHA | $5.89M | 4.33% | 0.66% | Not reported | Q4 2024 |
| ASMB | $4.5M | 3.31% | 1.11% | -7.2% | Q4 2024 |
| RARE | $4.06M | 2.99% | 0.14% | +22.7% | Q4 2024 |
| AURA | $3.54M | 2.60% | 0.91% | Not reported | Q4 2024 |
| IOVA | $3.26M | 2.39% | 0.39% | Not reported | Q4 2024 |
| SGHT | $3.2M | 2.35% | 1.77% | Not reported | Q4 2024 |
| SYRE | $1.68M | 1.23% | 0.17% | +25.0% | Q4 2024 |
| PRAX | $1.67M | 1.23% | 0.15% | -10.0% | Q1 2025 |
| ORKA | $1.44M | 1.06% | 0.16% | Not reported | Q4 2024 |
| APGE | $1.39M | 1.02% | 0.06% | Not reported | Q4 2024 |
 GAME | $170K | 0.12% | 0.25% | New | Q3 2025 |
 INSM | $22.8K | 0.02% | 0.00% | -99.9% | Q4 2024 |